GENEVA, Aug. 10 -- INNOLAKE BIOPHARMA (HANGZHOU) CO., LTD. (B 1003, NO.11, Lane 221, Dongyu Road, New Bund World Trade CenterPudong New Area, Shanghai 200126), 英诺湖医药(杭州)有限公司 (中国上海市浦东新区新区东育路221弄11号前滩世贸中心三期B栋1003单元) filed a patent application (PCT/CN2025/074146) for "MONOCLONAL ANTIBODY SPECIFICALLY BINDING TO PD-1 AND PHARMACEUTICAL USE THEREOF" on Jan 23, 2025. With publication no. WO/2025/162161, the details related to the patent application was published on Aug 07...